These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 30678118)

  • 1. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A; Donaubauer J; Kratzsch J; Pfaeffle R; Hirsch W; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency.
    Bizzarri C; Pedicelli S; Boscherini B; Bedogni G; Cappa M; Cianfarani S
    J Endocrinol Invest; 2015 Apr; 38(4):429-36. PubMed ID: 25376365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood.
    Bonfig W; Bechtold S; Bachmann S; Putzker S; Fuchs O; Pagel P; Schwarz HP
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1049-56. PubMed ID: 19189699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
    Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
    Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: retesting after one year of therapy and at final height.
    Thomas M; Massa G; Maes M; Beckers D; Craen M; François I; Heinrichs C; Bourguignon JP;
    Horm Res; 2003; 59(1):7-15. PubMed ID: 12566729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.
    Berberoğlu M; Sıklar Z; Darendeliler F; Poyrazoğlu S; Darcan S; Işgüven P; Bideci A; Ocal G; Bundak R; Yüksel B; Arslanoğlu I
    J Clin Res Pediatr Endocrinol; 2008; 1(1):30-7. PubMed ID: 21318062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements.
    Darendeliler F; Spinu I; Bas F; Bundak R; Isgüven P; Arslanoğlu I; Saka N; Sükür M; Günöz H
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):1007-12. PubMed ID: 15301049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.
    Castagno M; Monzani A; Zanetta S; Genoni G; Giglione E; Ricotti R; Bona G; Prodam F; Bellone S
    J Endocrinol Invest; 2018 Aug; 41(8):977-983. PubMed ID: 29423542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.